{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T03:32:09Z","timestamp":1764905529119},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1097\/wnf.0000000000000034","type":"journal-article","created":{"date-parts":[[2014,7,3]],"date-time":"2014-07-03T15:44:54Z","timestamp":1404402294000},"page":"91-95","source":"Crossref","is-referenced-by-count":16,"title":["Liquid Melevodopa Versus Standard Levodopa in Patients With Parkinson Disease and Small Intestinal Bacterial Overgrowth"],"prefix":"10.1097","volume":"37","author":[{"given":"Alfonso","family":"Fasano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Bove","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Gabrielli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enzo","family":"Ragazzoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serena","family":"Fortuna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annalisa","family":"Tortora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Assunta","family":"Zocco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Marconi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Gasbarrini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Rita","family":"Bentivoglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"suppl 3","key":"R1-1-20210203","doi-asserted-by":"crossref","first-page":"S497","DOI":"10.1002\/mds.22028","article-title":"The history of dopamine and levodopa in the treatment of Parkinsons disease.","volume":"23","author":"Fahn","year":"2008","journal-title":"Mov Disord"},{"key":"R2-1-20210203","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0733-8619(18)30213-5","article-title":"The natural history of Parkinsons disease in the pre-levodopa and post-levodopa eras.","volume":"10","author":"Hoehn","year":"1992","journal-title":"Neurol Clin"},{"key":"R3-1-20210203","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/mds.20243","article-title":"Levodopa in the treatment of Parkinsons disease: current controversies.","volume":"19","author":"Olanow","year":"2004","journal-title":"Mov Disord"},{"key":"R4-1-20210203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1468-1331.1999.610001.x","article-title":"Motor fluctuations in Parkinsons disease: pathophysiology and treatment.","volume":"6","author":"Colosimo","year":"1999","journal-title":"Eur J Neurol"},{"key":"R5-1-20210203","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1212\/WNL.46.4.1051","article-title":"Gastric emptying in Parkinsons disease: patients with and without response fluctuations.","volume":"46","author":"Djaldetti","year":"1996","journal-title":"Neurology"},{"key":"R6-1-20210203","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1212\/01.wnl.0000221672.01272.ba","article-title":"Helicobacter pylori eradication and l-dopa absorption in patients with PD and motor fluctuations.","volume":"66","author":"Pierantozzi, Pietroiusti","year":"2006","journal-title":"Neurology"},{"key":"R7-1-20210203","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1002\/mds.22190","article-title":"Helicobacter pylori infection and motor fluctuations in patients with Parkinsons disease.","volume":"23","author":"Lee","year":"2008","journal-title":"Mov Disord"},{"key":"R8-1-20210203","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/00002826-199402000-00012","article-title":"l-dopa malabsorption in a parkinsonian patient with Strongyloides stercoralis duodenitis.","volume":"17","author":"Gatto","year":"1994","journal-title":"Clin Neuropharmacol"},{"key":"R9-1-20210203","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/mds.23566","article-title":"Prevalence of small intestinal bacterial overgrowth in Parkinsons disease.","volume":"26","author":"Gabrielli","year":"2011","journal-title":"Mov Disord"},{"key":"R10-1-20210203","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/mds.25522","article-title":"The role of small intestinal bacterial overgrowth in Parkinsons disease.","volume":"28","author":"Fasano","year":"2013","journal-title":"Mov Disord"},{"key":"R11-1-20210203","first-page":"259","article-title":"The clinical efficacy of a single afternoon dose of levodopa methyl ester: a double-blind cross-over study versus placebo.","volume":"9","author":"Stocchi","year":"1994","journal-title":"Funct Neurol"},{"key":"R12-1-20210203","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/01.WNF.0000236762.77913.C6","article-title":"Clinical efficacy of a single afternoon dose of effervescent levodopa-carbidopa preparation (CHF 1512) in fluctuating Parkinson disease.","volume":"30","author":"Stocchi","year":"2007","journal-title":"Clin Neuropharmacol"},{"key":"R13-1-20210203","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/WNF.0b013e3181de8924","article-title":"Factors associated with motor fluctuations and dyskinesia in Parkinson disease: potential role of a new melevodopa plus carbidopa formulation (Sirio).","volume":"33","author":"Stocchi","year":"2010","journal-title":"Clin Neuropharmacol"},{"key":"R14-1-20210203","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/archneur.56.1.33","article-title":"Diagnostic criteria for Parkinson disease.","volume":"56","author":"Gelb","year":"1999","journal-title":"Arch Neurol"},{"key":"R15-1-20210203","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000103892","article-title":"Small intestinal bacterial overgrowth: diagnosis and treatment.","volume":"25","author":"Gasbarrini","year":"2007","journal-title":"Dig Dis"},{"issue":"Suppl 1","key":"R16-1-20210203","first-page":"1","article-title":"Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference.","volume":"29","author":"Gasbarrini","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"R17-1-20210203","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1007\/s10620-007-0065-1","article-title":"A systematic review of diagnostic tests for small intestinal bacterial overgrowth.","volume":"53","author":"Khoshini","year":"2008","journal-title":"Dig Dis Sci"},{"key":"R18-1-20210203","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/j.1365-2036.2004.02203.x","article-title":"Review article: 13C-urea breath test in the diagnosis of Helicobacter pylori infectiona critical review.","volume":"20","author":"Gisbert","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"R19-1-20210203","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1002\/mds.23429","article-title":"Systematic review of levodopa dose equivalency reporting in Parkinsons disease.","volume":"25","author":"Tomlinson","year":"2010","journal-title":"Mov Disord"},{"key":"R20-1-20210203","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/1531-8257(199907)14:4<572::AID-MDS1005>3.0.CO;2-C","article-title":"Core assessment program for surgical interventional therapies in Parkinsons disease (CAPSIT-PD).","volume":"14","author":"Defer","year":"1999","journal-title":"Mov Disord"},{"key":"R22-1-20210203","first-page":"353","article-title":"J Nerv Ment D","volume":"173","year":"1985","journal-title":"is"},{"key":"R23-1-20210203","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0378-4347(93)E0411-I","article-title":"Simultaneous determination of levodopa methyl ester, levodopa, 3-O-methyldopa and dopamine in plasma by high-performance liquid chromatography with electrochemical detection.","volume":"653","author":"Rondelli","year":"1994","journal-title":"J Chromatogr B Biomed Appl"},{"key":"R24-1-20210203","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/00002826-199106000-00007","article-title":"The clinical efficacy of oral levodopa methyl ester solution in reversing afternoon off periods in Parkinsons disease.","volume":"14","author":"Steiger","year":"1991","journal-title":"Clin Neuropharmacol"},{"key":"R25-1-20210203","first-page":"S46","article-title":"Clinical efficacy of single morning doses of two liquid formulations of levodopa: levodopabenserazide dispersible and melevodopacarbidopa effervescent.","volume":"24","author":"Fabbri","year":"2003","journal-title":"Neurological Sciences"},{"key":"R26-1-20210203","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/WNF.0b013e3181c5e60c","article-title":"Clinical experiences with levodopa methylester (melevodopa) in patients with Parkinson disease experiencing motor fluctuations: an open-label observational study.","volume":"33","author":"Zangaglia","year":"2010","journal-title":"Clin Neuropharmacol"},{"key":"R27-1-20210203","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1002\/mds.23206","article-title":"Melevodopacarbidopa effervescent formulation in the treatment of motor fluctuations in advanced Parkinsons disease.","volume":"25","author":"Stocchi","year":"2010","journal-title":"Mov Disord"}],"container-title":["Clinical Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/WNF.0000000000000034","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T07:09:42Z","timestamp":1620976182000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002826-201407000-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/wnf.0000000000000034","relation":{},"ISSN":["0362-5664"],"issn-type":[{"value":"0362-5664","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]}}}